Pharmaceutical Companies

Judge finds lawsuits allege deliberate, not accidental, conduct. McKesson says it has spent more than $270 million on opioid legal defense

Drugmaker Johnson & Johnson and three major distributors have finalized a nationwide settlement over their role in the opioid addiction crisis

6th Circuit cites risk of state, federal court friction. Ohio state courts are considering other opioid coverage disputes

Johnson & Johnson and its three largest drug distributors will pay a combined $26 billion to communities affected by the opioid crisis.

Over the next two weeks, some of the biggest U.S. corporations accused of "turbocharging" the opioid epidemic could finalize payouts to victims and governments worth roughly $32 billion.

Native American tribes have reached opioid settlements worth over a half-billion dollars with drugmaker Johnson & Johnson and three distributors

Three US drug distributors and drugmaker Johnson & Johnson agree to deal resolving tribal claims over opioid epidemic.

A group of pharmaceutical companies and distributors agreed to pay $590 million to settle lawsuits connected to opioid addiction among Native American tribes, according to a U.S. court filing released Tuesday.